Firoozbahr Meysam, Kingshott Peter, Palombo Enzo A, Zaferanloo Bita
Department of Chemistry and Biotechnology, School of Science, Computing and Engineering Technologies, Swinburne University of Technology, Hawthorn, VIC 3122, Australia.
ARC Training Centre Training Centre in Surface Engineering for Advanced Materials (SEAM), School of Engineering, Swinburne University of Technology, Hawthorn, VIC 3122, Australia.
Pharmaceutics. 2023 Feb 14;15(2):644. doi: 10.3390/pharmaceutics15020644.
Wound care is a global health issue with a financial burden of up to US $96.8 billion annually in the USA alone. Chronic non-healing wounds which show delayed and incomplete healing are especially problematic. Although there are more than 3000 dressing types in the wound management market, new developments in more efficient wound dressings will require innovative approaches such as embedding antibacterial additives into wound-dressing materials. The lack of novel antibacterial agents and the misuse of current antibiotics have caused an increase in antimicrobial resistance (AMR) which is estimated to cause 10 million deaths by 2050 worldwide. These ongoing challenges clearly indicate an urgent need for developing new antibacterial additives in wound dressings targeting microbial pathogens. Natural products and their derivatives have long been a significant source of pharmaceuticals against AMR. Scrutinising the data of newly approved drugs has identified plants as one of the biggest and most important sources in the development of novel antibacterial drugs. Some of the plant-based antibacterial additives, such as essential oils and plant extracts, have been previously used in wound dressings; however, there is another source of plant-derived antibacterial additives, i.e., those produced by symbiotic endophytic fungi, that show great potential in wound dressing applications. Endophytes represent a novel, natural, and sustainable source of bioactive compounds for therapeutic applications, including as efficient antibacterial additives for chronic wound dressings. This review examines and appraises recent developments in bioactive wound dressings that incorporate natural products as antibacterial agents as well as advances in endophyte research that show great potential in treating chronic wounds.
伤口护理是一个全球性的健康问题,仅在美国每年的经济负担就高达968亿美元。慢性难愈合伤口表现出愈合延迟和不完全愈合,尤其成问题。尽管伤口管理市场上有3000多种敷料类型,但开发更高效的伤口敷料需要创新方法,如将抗菌添加剂嵌入伤口敷料材料中。新型抗菌剂的缺乏和当前抗生素的滥用导致了抗菌耐药性(AMR)的增加,据估计到2050年全球将有1000万人死于AMR。这些持续存在的挑战清楚地表明,迫切需要在针对微生物病原体的伤口敷料中开发新的抗菌添加剂。天然产物及其衍生物长期以来一直是对抗AMR的重要药物来源。对新批准药物的数据进行审查后发现,植物是新型抗菌药物开发中最大且最重要的来源之一。一些基于植物的抗菌添加剂,如精油和植物提取物,此前已用于伤口敷料;然而,还有另一种植物源抗菌添加剂来源,即共生内生真菌产生的抗菌添加剂,在伤口敷料应用中显示出巨大潜力。内生菌是用于治疗应用的生物活性化合物的一种新型、天然且可持续的来源,包括作为慢性伤口敷料的高效抗菌添加剂。这篇综述研究并评估了将天然产物作为抗菌剂的生物活性伤口敷料的最新进展,以及在内生菌研究方面取得的进展,这些进展在治疗慢性伤口方面显示出巨大潜力。